Kwon Yu Jun, Park Ki Soo, Choi Bong Hoi, Kim Byung Sung, Ha Yong Chan
Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
Department of Preventive Medicine and Institute of Health Sciences, Gyeongsang National University, Jinju, Korea.
J Korean Med Sci. 2017 Feb;32(2):352-356. doi: 10.3346/jkms.2017.32.2.352.
This prospective intervention study was undertaken to estimate the prevalence and treatment rate of osteoporosis following osteoporosis screening tests in the same cohort. From November 1, 2014 to August 31, 2015, participants received screening tests for osteoporosis using ultrasound bone densitometry and education concerning osteoporosis and related conditions. The participants were interviewed using a questionnaire on the diagnosis and initiation of osteoporosis treatment during the follow-up period. Of 960 potential participants, 595 people (68.8%; 150 men and 445 women) were given bone densitometry measurements and completed the questionnaire. The mean age of the participants was 74.0 years. Of the 595 participants, 393 people (66.1%; 67 men and 326 woman) were diagnosed with osteoporosis (T score < -2.5). The prevalence of osteoporosis showed an increasing trend, from 48.1% in 2004 to 66.1% in 2015. Of the 393 participants diagnosed with osteoporosis, 65 participants received additional bone densitometry measurements while hospitalized and osteoporosis management was re-initiated in 44 patients. The osteoporosis management rate in the study cohort increased from 21.6% to 32.8%, with osteoporosis diagnosed in 66.2% of participants at the latest follow-up. This prospective intervention study demonstrated that a screening test and an educational brochure increased the treatment rate from 21.6% to 32.8%.
本前瞻性干预研究旨在评估同一队列中骨质疏松症筛查试验后骨质疏松症的患病率和治疗率。2014年11月1日至2015年8月31日,参与者接受了超声骨密度测定的骨质疏松症筛查试验以及有关骨质疏松症和相关病症的教育。在随访期间,使用关于骨质疏松症诊断和治疗开始情况的问卷对参与者进行访谈。在960名潜在参与者中,595人(68.8%;150名男性和445名女性)接受了骨密度测量并完成了问卷。参与者的平均年龄为74.0岁。在595名参与者中,393人(66.1%;67名男性和326名女性)被诊断为骨质疏松症(T值<-2.5)。骨质疏松症的患病率呈上升趋势,从2004年的48.1%升至2015年的66.1%。在393名被诊断为骨质疏松症的参与者中,65名参与者在住院期间接受了额外的骨密度测量,44名患者重新开始了骨质疏松症管理。研究队列中的骨质疏松症管理率从21.6%升至32.8%,在最新随访中66.2%的参与者被诊断为骨质疏松症。这项前瞻性干预研究表明,筛查试验和教育手册将治疗率从21.6%提高到了32.8%。